PD-1 inhibitors versus chemotherapy as second-line treatment for advanced esophageal squamous cell carcinoma: a meta-analysis

PD-1 inhibitors versus chemotherapy as second-line treatment for advanced esophageal squamous cell carcinoma: a meta-analysis

Abstract Background Aim to establish the inhibitors of programmed cell death protein 1 (PD-1) as second-line therapy for advanced esophageal squamous cell carcinoma (ESCC). Methods Published clinical trials in the PubMed, Medline, Embase databases on PD-1 inhibitors for the treatment of ESCC were se...

Full description

Bibliographic Details
Main Authors: Xinxin Zhu, Qiyue Shanzhou, Danyang Li, Xuezhou Pang, Daiyuan Ma
Format: Article
Language:English
Published: BMC 2021-11-01
Series:BMC Cancer
Subjects:
PD-1
Chemotherapy
Esophageal squamous cell carcinoma
Efficacy
Safety
meta-analysis
Online Access:https://doi.org/10.1186/s12885-021-08958-3

Internet

https://doi.org/10.1186/s12885-021-08958-3

Similar Items